AzTrials
AzTrials

Non-suicidal Self-injuryVRNCT05734872

Research on the Intervention of VR-based Emotion Regulation Technology on Adolescent Non-suicide Self-injury Behavior

A study testing Virtual Reality Technology and Routine mental health course training in people with Non-suicidal Self-injury, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Non suicidal self injury (NSSI) has become a serious social and public health problem allover the world, and the incidence rate is increasing year by year. Although the aim of NSSI is not to suicide, but its negative impact is extremely serious, which will seriously threaten the physical and mental health of… Read more about this study

Who is it for?
Ages 18 to 24 years
Conditions the study is for
Non-suicidal Self-injury
What is being tested?
Virtual Reality Technology and Routine mental health course training
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteChina
Study dates
26 Oct 2022to 26 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • According to the diagnostic criteria of NSSI in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders.
  • Have a past history of non-suicidal self-injury behavior.
  • No virtual reality technology intervention before enrollment.
  • age: ≥ 18 to<24.

Who cannot join

  • Those who have serious physical diseases
  • Those who cannot cooperate with the completion of virtual reality technology finally complete the intervention content<50%.

Trial locations and contacts

1 site in 1 country.

Fang Chen, bachelor contact

+86 15867161868

2201066@zju.edu.cn

China1 site, 1 recruiting
  • Second Affiliated Hospital of Zhejiang University

    Hangzhou, Zhejiang

    Recruiting

Other trials in China

About this study

Official title: Psychiatry Department of The Second Affiliated Hospital of Zhejiang University School of Medicine

Non suicidal self injury (NSSI) has become a serious social and public health problem allover the world, and the incidence rate is increasing year by year. Although the aim of NSSI is not to suicide, but its negative impact is extremely serious, which will seriously threaten the physical and mental health of adolescents. Virtual Reality (VR), a computer simulation technology, can enable people to enter and experience the artificial virtual world in an immersive way, has been used for the auxiliary treatment of anxiety disorder, post-traumatic stress disorder and other diseases. This study explored the impact of VR on the depression and mental health of NSSI adolescents, so as to reduce the incidence of non-suicide self-injury behavior in NSSI adolescent patients and improve the quality of life of such patients.

Being tested
Virtual Reality Technology, Routine mental health course training
Keywords
Non-suicidal Self-injury, Virtual Reality Technology, Adolescent
Medical subject headings
Self-Injurious Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality TechnologyDevice

    Make a pair of glasses through virtual reality technology, through which participants can observe and participate in the treatment process.

  • Routine mental health course trainingOther

    Conduct mental health education for patients by making a speech.

Study groups in NCT05734872
Study groupRoleWhat they receive
Experimental groupExperimentalNot described
Receives: Device: Virtual Reality Technology
Control groupOtherNot described
Receives: Other: Routine mental health course training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ottawa Self-injury Inventory Chinese Revision

    This item describes the addictive characteristics of non-suicidal self-injury behavior. There are seven items in total. Add the seven items to get the original total score. The higher the original total score, the more addictive the non-suicidal self-injury behavior of the individual. The minimum value is 0 and maximum value is 28.

    Measured: up to one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start26 Oct 2022
  3. Primary completion26 Dec 2023 (estimated)
  4. Study completion26 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05734872
Sponsor's protocol ID
2022-0754
Acronym
VR
Status last verified
Feb 2023
First submitted
7 Feb 2023
Last updated
21 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Technology and Routine mental health course training in people with Non-suicidal Self-injury, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Fang Chen, bachelor (+86 15867161868, 2201066@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ottawa Self-injury Inventory Chinese Revision (time frame: up to one month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in